The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.
Anna A Helgadottir,
Andrei A Manolescu,
Gudmar G Thorleifsson,
Solveig S Gretarsdottir,
Helga H Jonsdottir,
Unnur U Thorsteinsdottir,
Nilesh J NJ Samani,
Gudmundur G Gudmundsson,
Struan F A SF Grant,
Gudmundur G Thorgeirsson,
Sigurlaug S Sveinbjornsdottir,
Einar M EM Valdimarsson,
Stefan E SE Matthiasson,
Halldor H Johannsson,
Olof O Gudmundsdottir,
Mark E ME Gurney,
Jesus J Sainz,
Margret M Thorhallsdottir,
Margret M Andresdottir,
Michael L ML Frigge,
Eric J EJ Topol,
Augustine A Kong,
Vilmundur V Gudnason,
Hakon H Hakonarson,
Jeffrey R JR Gulcher and
Kari K Stefansson
Nat Genet 36(3):233-9 (2004)
PMID 14770184
We mapped a gene predisposing to myocardial infarction to a locus on chromosome 13q12-13. A four-marker single-nucleotide polymorphism (SNP) haplotype in this locus spanning the gene ALOX5AP encoding 5-lipoxygenase activating protein (FLAP) is associated with a two times greater risk of myocardial infarction in Iceland. This haplotype also confers almost two times greater risk of stroke. Another ALOX5AP haplotype is associated with myocardial infarction in individuals from the UK. Stimulated neutrophils from individuals with myocardial infarction produce more leukotriene B4, a key product in the 5-lipoxygenase pathway, than do neutrophils from controls, and this difference is largely attributed to cells from males who carry the at-risk haplotype. We conclude that variants of ALOX5AP are involved in the pathogenesis of both myocardial infarction and stroke by increasing leukotriene production and inflammation in the arterial wall.
DOI: 10.1038/ng1311
Version: za2963e q8za9 q8zb9 q8zc0 q8zd3 q8zed q8zf8 q8zg9
Viewers of this paper also looked at these papers: